Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera.

Cite this paper

@article{Wernig2008EfficacyOT, title={Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera.}, author={Gerlinde Wernig and Michael G Kharas and Rachel O. Okabe and Sandra A. Moore and Dena S. Leeman and Dana E. Cullen and Maricel Gozo and Elizabeth P. McDowell and Ross L. Levine and John A. Doukas and Chi Ching Mak and Glenn Noronha and Michael B. Martin and Yon - Dschun Ko and Benjamin Hoyoung Lee and Richard M Soll and Ayalew Tefferi and John D. Hood and Dwight Gary Gilliland}, journal={Cancer cell}, year={2008}, volume={13 4}, pages={311-20} }